Found "AI": 1,167 results
Sort by
Relevance

Growing Older Together: Is ASEAN Ready for Happy Ageing?

Living longer is inevitable. Living better requires policy choices. Happy ageing is achieved through policy impact, not policy volume. ASEAN does not lack ageing policies — it lacks evidence on what works. While many Member States have introduced national plans, pensions, and health programme

Target product profiles: opportunities and implications for health innovation development–a scoping review

Highlights By reviewing 120 Target Product Profiles (TPPs), this study identified key aspects of TPP development processes, stakeholder involvement, common themes, major limitations, and priorities for follow-up research. Health technologies were classified into five categories, and the pr

Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le

Early Health Technology Assessment of Non-sputum-based Assays for Screening and Treatment Monitoring in a prospective cohort of pulmonary tuberculosis

Tuberculosis is caused by bacterium called Mycobacterium tuberculosis. It is a significant problem in Thailand as seen that in 2021 Thailand is in the World Health Organization’s list of 30 high-burden countries for tuberculosis. One of the problems about tuberculosis is inaccurate diagnosis due to insufficient sensitivity and specificity of prim

A scoping review of modelling in target product profile development for medical innovation

Background Target Product Profiles (TPPs) serve as strategic tools for planning medical innovation development, facilitating communication with regulators, and developing market access strategies. Modelling can assist TPPs development and provide guidance on defining attributes. This scoping review

Early Health Technology Assessment of herbal extracts for Metabolic Syndrome

The project aims to evaluate the cost-effectiveness, economic impact, and feasibility of integrating this herbal innovation into Thailand’s healthcare system. By applying Early HTA techniques, this study will provide insights for decision-makers, improve resource allocation, and support future investments in innovative medical solutions.67301075M

Rethinking The Role Of Health Technology Assessment: From Gatekeeper To Health System Shaper

Abstract The role of Health Technology Assessment (HTA) is evolving. Once seen primarily as a gatekeeper, HTA is increasingly viewed as a potential shaper of health system transformation. The first plenary session of the HTA International 2025 Annual Meeting, explored the potential for HTA to ado

Linking VOC assessment and cost-effectiveness for emission management in petroleum and petrochemical industrial estate

Abstract Managing volatile organic compound (VOC) emissions in industrial complexes requires clear links between emission sources, atmospheric dispersion, and their contributions to ambient exposure. This study links VOC assessment and cost-effectiveness analysis to support emission management in

Development of a practical guidebook on Medical Technology Development

This project aims to develop a practical guidebook on medical technology development. It is funded by the Department of Medical Sciences, Ministry of Public Health, and aims to explain the concepts, processes, and outcomes of medical technology development in the Thai context. This guidebook is intended to serve as a reliable internal reference doc

Early Health Technology Assessment of an Osteoporosis Screening Machine using Machine Learning

Osteoporosis is one of the major public health problems in Thailand, particularly among postmenopausal women and the continuously increasing elderly population. This condition causes a significant disease burden from fractures, leading to patient disability, reduced quality of life, and high expenditures for both the patients themselves and the hea
10 / Page